Recently, Mr. Makoto Inoue, President and Representative Director of Otsuka Pharmaceutical Co., Ltd. and Representative Director, COO of Otsuka Holdings Co., Ltd., Pharmavite’s parent company, visited Bonafide Health, the newest addition to Pharmavite’s market-leading portfolio of women’s health brands. During his visit, Mr. Inoue shared more about Otsuka’s priorities and commitment to women’s health, as well as connected with members of the Bonafide team to find opportunities to collaborate on a global level. To learn more about Otsuka, visit: https://lnkd.in/g3WX_Miu
On May 15th, 2024, Bonafide had the pleasure of hosting Mr. Makoto Inoue, President and Representative Director of Otsuka Pharmaceutical Co., Ltd. and Representative Director, COO of Otsuka Pharmaceutical Companies (U.S.) Holdings Co., Ltd. – parent company of Pharmavite, who recently acquired Bonafide Health in November of 2023 – at the company’s headquarters in Harrison, NY. Mr. Inoue’s visit served to inform Bonafide, the newest addition to Pharmavite’s growing portfolio of innovative women’s health brands, about future research plans, areas of focus and to identify strategic opportunities for global collaboration and expansion of the valuable synergies between the companies. We look forward to continuing to spearhead groundbreaking scientific studies and developing our growing suite of products to better support the increased demand for clinically backed products designed for supporting common women’s health needs. #innovation #vitaminsandsupplements #VMS #womenshealth #womenshealthmatters #menopause #perimenopause #RandD
